Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events

Immune-related cutaneous adverse events (ircAEs) commonly occur in patients on treatment with immune checkpoint inhibitors and can significantly reduce patient quality of life. These are often treated with immunomodulatory agents, including glucocorticoids, immunosuppressants, and biologics. While o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Stephanie L., Nath, Sandy, Markova, Alina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674388/
https://www.ncbi.nlm.nih.gov/pubmed/38004475
http://dx.doi.org/10.3390/ph16111610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674388/
https://www.ncbi.nlm.nih.gov/pubmed/38004475
http://dx.doi.org/10.3390/ph16111610

Ejemplares similares